Namax Medical AB
ActiveKey figures
Key figures
2025Summary: Namax Medical AB
What kind of company is it?
Namax Medical AB (org. no. 559260-1263) is a limited company (AB). The company was registered in 2020 and has existed for 6 years. Registered seat: Stockholm. Industry according to Statistics Sweden: specialist medical practice activities, not at hospitals (SNI 86222).
How is the company doing financially?
Net sales in financial year 2025 were 283 000 kr. From 2020 to 2025, net sales grew by an average of 19,1 % per year. Net profit for 2025 was 137 315 kr (48,5 % of net sales). The company was profitable in 5 of the 6 reported financial years. At the end of financial year 2025, total assets were 319 000 kr and equity 246 445 kr (equity ratio 77,3 %). The annual report for 2025 proposes a dividend of 200 000 kr.
Where does the data come from and how up to date is it?
Company details and digitally filed annual reports come from the open data of the Swedish Companies Registration Office (Bolagsverket) and the industry code from Statistics Sweden (CC BY 2.5 SE); bolagsprofil.se updates them daily. The latest annual report is signed by 3 people. Data as of 2026-11-16. Changes, averages and ratios are calculated by bolagsprofil.se from open data and are not an official assessment.
Dividend
from the annual reportProposed dividend 200 000 kr.
Summary of annual reports2020–2025
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Sales revenue | 567 000 | 122 000 | 45 000 | −4 000 | 283 000 |
| Profit for the reporting year | 398 957 | 43 125 | 17 760 | −38 867 | 137 315 |
| Retained earnings of previous periods | — | — | — | — | — |
| Total assets | 567 733 | 417 873 | 260 137 | 221 167 | 319 000 |
| Total liabilities | 135 620 | 92 636 | 12 140 | 12 037 | 72 555 |
| Total equity | 432 113 | 325 237 | 247 997 | 209 130 | 246 445 |
| Employees | — | — | — | — | — |
| Proposed dividend | — | — | — | — | 200 000 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.